The Biological Products Industry Alliance (BPIA) celebrates the August 27, 2024, signing of California Senate Bill (SB) 1522 by Governor Gavin Newsom, which establishes a comprehensive framework for biostimulants in the state. This landmark legislation marks a significant advancement towards the implementation of the AAPFCO model bill. Key provisions of SB 1522 include:
- Clear definition and classifications for biostimulants
- Streamlined registration processes for manufacturers
- Guidelines for product labeling and efficacy claims
The passage of this bill aligns with BPIA’s mission to promote sustainability through biological solutions, fostering innovation, and ensuring product integrity in agriculture. BPIA extends its gratitude to the California State Legislature and Governor Newsom for their leadership in this initiative. This legislation sets a precedent for other states to follow, advancing the adoption of biostimulants and other biological solutions nationwide.
To read the entire bill click here.
For more information or questions please contact:
Jones@bpia.org
